Ramsay Santé, a group of private clinics present in 5 countries, wants to improve the care and monitoring of cancer patients. He has just announced in a press release the launch of two projects under article 51 of the social security financing law, which makes it possible to test new devices in the health sector.
Promote physical activity
The first device started from the observation that “the introduction of physical activity into the post-cancer care pathway presented several limits: lack of adherence to the programs put in place, inequality in access to resources, lack of coordination and information sharing between different stakeholders … “, explains Aurélie Clerquin, project manager at the Lille Métropole cancer institute.
To address this issue, Ramsay Santé has teamed up with the start-up Kiplin to develop a mobile application that offers patients, accompanied by a coordinating nurse, a 12-week program alternating “fun and connected activities” and adapted physical activity sessions (APA).
The device includes a “videoconference” mode dedicated to patients not wishing or unable to travel in the health establishment. An important issue in the midst of the Covid-19 pandemic.
A cohort of 500 patients
According to Kiplin, “70% of participants increase their physical activity by more than 50% compared to their habits”. The target population is 500 patients who have completed their treatment for digestive cancer or breast cancer at the private hospital? la Louvie? re, that of Villeneuve d’Ascq and du Bois as well as the Clinique de la Victoire.
The second device, called “Metis Connect”, is “digital patient monitoring both during and outside of episodes of care“, details Carole Micheneau, referent of the oncology sector at Ramsay Santé. Relying on the solution of the company Exolis, this application should make it possible to initiate as early as possible a support program connected between the actions carried out at the Jean Mermoz Cancer Institute, located in Lyon, and at home.
Continuous monitoring of side effects
“Metis Connect” will also be dedicated to setting up continuous home monitoring for the side effects of chemotherapy. This monitoring should allow “early adaptation of treatment and recourse to supportive care”, specifies the health group, which adds that this experiment will reduce health insurance costs linked to complications in support.
This 4-year project concerns new patients treated at Jean Mermoz hospital for digestive cancer, which corresponds to approximately 500 people per year. In order to demonstrate the reproducibility of the experiment, Ramsay Santé will integrate this system in two other establishments in the Auvergne-Rhône-Alpes region.
–
